Revvity

Revvity is a health science solutions provider that aims to expand the boundaries of human potential through science. With the slogan "Expanding the boundaries of human potential through science," the company is on a mission to challenge the notion of the "impossible" and turn "can't be done" into a call to action. It offers a wide range of technologies, expertise, and services that cover complete workflows from discovery to development, and diagnosis to cure. Specializing in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics, and more, Revvity is at the forefront of revolutionizing what’s possible in healthcare.

Founded in 2023, Revvity has quickly made a mark in the industry, generating over $3 billion in revenue and employing more than 11,000 individuals. The company's customer base spans across pharmaceutical and biotech, diagnostic labs, academia, and governments, with a global presence in over 190 countries. As an indication of its success and market position, Revvity is part of the S&P 500 index, highlighting its significance in the market.

Given its strong financial standing, expansive reach, and innovative offerings, Revvity presents an intriguing investment opportunity for venture capitalists looking to fund groundbreaking advancements in the healthcare industry. Notably, the company's ability to drive change and cater to diverse customer segments positions it favorably for potential partnerships and growth opportunities. Venture capitalists should keep a close watch on Revvity as it continues to shape the future of healthcare. Learn more at www.revvity.com.